Fas and perforin are not required for thymus atrophy induced by Trypanosoma cruzi infection

Experimental Parasitology

Volumn 107, Issue 1-2, 2004, Pages 1-4

  Henriques Pons, A ^a,b   DeMeis, J ^a   Cotta De Almeida, V ^a   Savino, W ^a   Araujo Jorge T C ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Cytotoxicity; Fas; gld; Perforin; Thymic atrophy; Trypanosoma cruzi

Indexed keywords

FAS ANTIGEN; PERFORIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CONTROLLED STUDY; CYTOTOXICITY; EVALUATION; KINETICS; MOLECULE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTOZOAL INFECTION; THYMUS ATROPHY; TRYPANOSOMA CRUZI;

ANIMALS; ANTIGENS, CD95; ATROPHY; CHAGAS DISEASE; DISEASE MODELS, ANIMAL; FAS LIGAND PROTEIN; FLOW CYTOMETRY; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PORE FORMING CYTOTOXIC PROTEINS; THYMUS GLAND;

TRYPANOSOMA; TRYPANOSOMA CRUZI;

EID: 2942641962     PISSN: 00144894     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exppara.2004.04.010     Document Type: Article

References (22)

1. Cotta-de-Almeida V., Bertho A.L., Villa-Verde D.M., Savino W. Phenotypic and functional alterations of thymic nurse cells following acute Trypanosoma cruzi infection. Clin. Immunol. Immunopathol. 82:1997;125-132
2. + thymocytes and activated mature lymphocytes in normal mice but not in the lupus-prone strain, MRL lpr/lpr. Proc. Natl. Acad. Sci. USA. 90:1993;10340-10344
3. French L.E., Wilson A., Hahne M., Viard I., Tschopp J., MacDonald H.R. Fas ligand expression is restricted to nonlymphoid thymic components in situ. J. Immunol. 159:1997;2196-2202
4. Henriques-Pons A., Oliveira G.M., Paiva M.M., Correa A.F.S., Batista M.B., Bisaggio R.C., Liu C.-C., Cotta-De-Almeida V., Persechini P.M., Araújo-Jorge T.C. Evidence of a perforin-mediated mechanism controlling cardiac inflammation in Trypanosoma cruzi infection. Int. J. Exp. Pathol. 83:2002;67-79
5. Kishimoto H., Surh C.D., Sprent J. A role for Fas in negative selection of thymocytes in vivo. J. Exp. Med. 187:1998;1427-1438
6. Kurasawa K., Hashimoto Y., Kasai M., Iwamoto I. The fas antigen is involved in thymic T-cell development as a costimulatory molecule, but not in the deletion of neglected thymocytes. J. Allergy Clin. Immunol. 106:2000;S19-31
7. Leguizamon M.S., Mocetti E., Garcia Rivello H., Argibay P., Campetella O. Trans-sialidase from Trypanosoma cruzi induces apoptosis in cells from the immune system in vivo. J. Infect. Dis. 180:1999;1398-1402
8. Leite-de-Moraes M.C., Hontebeyrie-Joskowicz M., Leboulenger F., Savino W., Dardenne M., Lepault F. Studies on the thymus in Chagas' disease. II. Thymocyte subset fluctuations in Trypanosoma cruzi-infected mice: relationship to stress. Scand. J. Immunol. 33:1991;267-275
9. Liu C.-C., Walsh C.M., Young J.D-E. Perforin: structure and function. Immunol. Today. 16, 1995;194-201
10. Lopes M.F., Nunes M.P., Henriques-Pons A., Giese N., Morse 3rd H.C., Davidson W.F., Araújo-Jorge T.C., DosReis G.A. Increased susceptibility of Fas ligand-deficient gld mice to Trypanosoma cruzi infection due to a Th2-biased host immune response. Eur. J. Immunol. 29:1999;81-89
11. + double-positive thymocytes in mice infected with Trypanosoma cruzi. Microbes Infect. 5:2003;1363-1371
12. Minoprio P.M., Eisen H., Forni L., D'Imperio Lima M.R., Joskowicz M., Coutinho A. Polyclonal lymphocyte responses to murine Trypanosoma cruzi infection. I. Quantitation of both T- and B-cell responses. Scand. J. Immunol. 24:1986;661-668
13. Moulian N., Renvoize C., Desodt C., Serraf A., Berrih-Aknin S. Functional Fas expression in human thymic epithelial cells. Blood. 93:1999;2660-2670
14. Mucci J., Hidalgo A., Mocetti E., Argibay P.F., Leguizamón S., Campetella O. Thymocyte depletion in Trypanosoma cruzi infection is mediated by trans-sialidase-induced apoptosis on nurse cells complex. Proc. Natl. Acad. Sci. USA. 99:2002;3896-3901
15. Nishimura Y., Ishii A., Kobayashi Y., Yamasaki Y., Yonehara S. Expression and function of mouse Fas antigen on immature and mature T cells. J. Immunol. 154:1995;4395-4403
16. + thymocytes by the anti-Fas antibody. J. Exp. Med. 181:1995;485-491
17. Savino W., Leite-de-Moraes M.C., Hontebeyrie-Joskowicz M., Dardenne M. Studies on the thymus in Chagas' disease. I. Changes in the thymic microenvironment in mice acutely infected with Trypanosoma cruzi. Eur. J. Immunol. 19:1989;1727-1733
18. Suda T., Takahashi T., Golstein P., Nagata S. Molecular cloning and expression of the Fas ligant, a novel member of the tumor necrosis factor family. Cell. 75:1993;1169-1178
19. Tarleton R.L. Trypanosoma cruzi-induced suppression of IL-2 production. II. Evidence for a role for suppressor cells. J. Immunol. 140:1988;2769-2773
20. Trapani J.A., Jans D.A., Jans P.J., Smyth M.J., Browne K.A., Sutton V.R. Efficient nuclear targeting of granzyme B and the nuclear consequences of apoptosis induced by granzyme B and perforin are caspase-dependent, but cell death is caspase-independent. J. Biol. Chem. 273:1998;27934-27938
21. Vandekerckhove B.A., Barcena A., Schols D., Mohan-Peterson S., Spits H., Roncarolo M.G. In vivo cytokine expression in the thymus. CD3high human thymocytes are activated and already functionally differentiated in helper and cytotoxic cells. J. Immunol. 152:1994;1738-1743
22. Young J.D.-E., Cohn Z.A., Podack E.R. The ninth component of complement and the pore-forming protein (perforin I) from cytotoxic T cells: structural, immunological and functional similarities. Science. 233:1986;184-290